Phencyclidine: The Chemistry and Clinical Reality of a Potent Dissociative Anesthetic
In short: Phencyclidine, or PCP, is a synthetic arylcyclohexylamine that functions as an NMDA receptor antagonist. While often associated with extreme street-level myths, its chemical profile reveals a complex substance with a history of medicinal use, significant psychological effects, and a unique molecular structure that continues to challenge forensic toxicology.
Chemically identified as 1-(1-phenylcyclohexyl)piperidine, phencyclidine is a white, crystalline powder with a molecular weight of 243.4 g/mol. It belongs to the cyclohexylamine family and is characterized by a high degree of lipophilicity, with a logP value of approximately 4.69. This hydrophobic nature allows the free base form to be absorbed through skin and mucous membranes, a property that has contributed to its varied routes of administration, including smoking, insufflation, and injection.
The drug's primary mechanism of action involves blocking NMDA receptors, which induces a dissociative state. Clinically, this manifests in a range of behavioral and psychological effects, including depersonalization, loss of ego boundaries, and altered body image. While media reports from the 1970s often sensationalized PCP-induced violence, modern clinical perspectives suggest such incidents are rare and frequently linked to pre-existing aggressive tendencies rather than the drug itself. Management of acute intoxication focuses on supportive care and the use of benzodiazepines to mitigate agitation or seizures.
Forensic analysis of PCP and its derivatives, such as 3-chloro-phencyclidine (3-Cl-PCP), remains a critical challenge in toxicology. Studies on 3-Cl-PCP fatalities demonstrate that the parent compound often accumulates in bile, with concentrations reaching up to 4300 ng/mL in post-mortem cases. Metabolism typically involves extensive hydroxylation of the cyclohexyl and piperidine rings, followed by glucuronidation. Accurate detection in clinical or forensic settings requires sophisticated techniques like liquid chromatography-tandem mass spectrometry, often necessitating enzymatic cleavage steps to identify metabolites effectively.
The legacy of phencyclidine is marked by its transition from a 1950s medicinal agent to a controlled substance. Despite its classification as a DEA Schedule II drug, it remains a subject of intense study due to its ability to induce ΔFosB expression in the nucleus accumbens, which underscores its addictive potential. Understanding its metabolic pathways and pharmacological impact is essential for managing the risks associated with its illicit use and the emergence of novel psychoactive analogs.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Phencyclidine
- Also: Phencyclidine
- Also: Phase I Metabolism of Novel Phencyclidine Derivative 3-Cl-PCP: In Vitro Studies With Pooled Human Liver Microsomes and Investigation of a Post-Mortem Case.
To cite this card, link to https://intellectplus.co.uk/app/health-phencyclidine.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Drugs and medication · More in Health · Latest · A–Z · All topics
